NCT06423365
- Conditions
- Cardiovascular Diseases, Dyslipidemias, Hydroxymethylglutaryl-CoA Reductase Inhibitors, +7 more
- Locations
-
- Kaiser Permanente Colorado Aurora, Colorado, United States
Clinical trial condition
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Explore clinical trials studying Hydroxymethylglutaryl-CoA Reductase Inhibitors. Study availability and eligibility vary by location and protocol.
8 public trials
0 recruiting studies
Hydroxymethylglutaryl-CoA Reductase Inhibitors trial results
Completed
Statins in Patients With Type 2 Diabetes Mellitus and Previous History of Acute Coronary Syndrome
NCT05306990
- Conditions
- Acute Coronary Syndrome, Cardiovascular Diseases, Diabetes Mellitus, +8 more
- Locations
-
- Heart Institute Cairo, Egypt
NCT03785509
- Conditions
- Adherence, Medication, Behavior, Compliance, Medication, +9 more
- Locations
-
- Samsung Medical Center Seoul, Gang nam-Gu, Ilwon-Dong, South Korea
Completed
Early Use of Rosuvastatin in Acute Coronary Syndromes: Targeting Platelet-Leukocyte Interactions
NCT01241903
- Conditions
- Acute Coronary Syndrome, Angioplasty, Transluminal, Percutaneous Coronary, Blood Platelets, +5 more
- Locations
-
- University of Kentucky Dept of Cardiology Lexington, Kentucky, United States
NCT03018444
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- University Hospital, Gentofte, Copenhagen Hellerup, Capital Region, Denmark
NCT01200056
- Conditions
- Cardiovascular Diseases, Coronary Disease, Heart Diseases, +4 more
- Locations
-
- Department of Medicine, the University of Hong Kong, Queen Mary Hospital, Hospital Authority Hong Kong SAR, Hong Kong, China
NCT00609063
- Conditions
- Hydroxymethylglutaryl-CoA Reductase Inhibitors, Muscle Cramp, Muscular Diseases, +10 more
- Locations
-
- Hartford Hospital Hartford, Connecticut, United States
- University of Connecticut Storrs, Connecticut, United States
- University of Massachusetts Amherst, Massachusetts, United States
Active, Not Recruiting
Efficacy and Safety of Pitavastatin and PCSK9 Inhibitors in Liver Transplant Patients
NCT05537948
- Conditions
- Dyslipidemias, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hyperlipidemias, +6 more
- Locations
-
- National Medical Research Centre for Therapy and Preventive Medicine of the Ministry of Health of Russia Moscow, Russia